CFR makes firm offer for Adcock Ingram

18 November 2013 - Deborah Wilkes

Archived

Chile's CFR Pharmaceuticals has now made a firm offer to purchase South Africa's Adcock Ingram in a cash and share deal worth ZAR12.6 billion (US$1.30 billion). The news follows weeks of speculation about shareholder support for the proposed deal and possible competing bids.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: